Key regions: Japan, India, Italy, Brazil, South Korea
The Anti-Hypertensive Drugs market in Qatar has been showing significant growth in recent years.
Customer preferences: Qatar's population is aging, and with age comes an increased risk of hypertension. As a result, there has been a growing demand for anti-hypertensive drugs in the country. Additionally, there is a high prevalence of obesity and diabetes in Qatar, which are both risk factors for hypertension. This has further fueled the demand for these drugs.
Trends in the market: The Anti-Hypertensive Drugs market in Qatar has been growing steadily due to several factors. Firstly, there has been an increase in the number of people diagnosed with hypertension in the country. This has led to a rise in the number of prescriptions for anti-hypertensive drugs. Secondly, there has been an increase in the availability of these drugs in Qatar. Several international pharmaceutical companies have entered the Qatari market, offering a wider range of drugs to consumers. Finally, there has been a shift towards more effective and innovative drugs, which has driven up the demand for these products.
Local special circumstances: Qatar has a high-income economy, which has enabled the country to invest heavily in its healthcare system. The government has been proactive in promoting healthy lifestyles and providing access to healthcare services. This has led to an increase in the number of people seeking medical attention for hypertension, which has contributed to the growth of the Anti-Hypertensive Drugs market in Qatar.
Underlying macroeconomic factors: Qatar's economy is heavily dependent on its oil and gas industry, which has been affected by fluctuations in global oil prices. However, the government has implemented several measures to diversify the economy and reduce its reliance on oil and gas. This has led to the growth of other sectors, including healthcare. As a result, there has been an increase in investment in the healthcare sector, which has contributed to the growth of the Anti-Hypertensive Drugs market in Qatar.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
